Elevance Health Inc. (ELV)
NYSE
Market Cap
$88.71B
Sector
Healthcare
Industry
Medical—Healthcare Plans
Rank in Sector
452 of 954
Rank in Industry
9 of 11
Largest Insider Buys in Sector
ELV Stock Price History Chart
ELV Stock Performance
About Elevance Health Inc.
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Insider Activity of Elevance Health Inc.
Over the last 12 months, insiders at Elevance Health Inc. have bought $0 and sold $44.23M worth of Elevance Health Inc. stock.
On average, over the past 5 years, insiders at Elevance Health Inc. have bought $1.5M and sold $28.25M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,300 shares for transaction amount of $499,668 was made by Schneider Ryan M. (director) on 2021‑07‑23.
List of Insider Buy and Sell Transactions, Elevance Health Inc.
| 2024-10-18 | Sale | EVP & President, Commercial | 7,417 0.0034% | $432.14 | $3.21M | -6.55% | ||
| 2024-08-05 | Sale | director | 753 0.0004% | $531.52 | $400,235 | -16.16% | ||
| 2024-07-22 | Sale | President and CEO | 34,000 0.018% | $500.98 | $17.03M | -2.04% | ||
| 2024-07-19 | Sale | director | 305 0.0002% | $506.76 | $154,562 | -1.29% | ||
| 2024-04-24 | Sale | EVP & President,Gov Health Ben | 6,199 0.0035% | $532.44 | $3.3M | -1.11% | ||
| 2024-04-23 | Sale | EVP & President,Gov Health Ben | 14,111 0.008% | $533.74 | $7.53M | -0.90% | ||
| 2024-03-08 | Sale | EVP & President, Commercial | 2,432 0.0013% | $500.46 | $1.22M | +3.91% | ||
| 2024-03-06 | Sale | CAO & Controller | 916 0.0005% | $504.58 | $462,195 | +3.74% | ||
| 2024-03-04 | Sale | EVP & Pres Carelon & CarelonRx | 21,095 0.0112% | $500.18 | $10.55M | +3.57% | ||
| 2024-02-07 | Sale | director | 753 0.0004% | $500.00 | $376,500 | +3.67% | ||
| 2023-12-14 | Sale | EVP, CLO & CAO | 5,492 0.0028% | $484.02 | $2.66M | +6.70% | ||
| 2023-11-30 | Sale | CAO & Controller | 1,055 0.0005% | $475.17 | $501,304 | +7.11% | ||
| 2023-10-24 | Sale | CAO & Controller | 64 <0.0001% | $454.35 | $29,078 | +13.44% | ||
| 2023-07-21 | Sale | director | 310 0.0002% | $476.71 | $147,780 | +2.09% | ||
| 2023-03-24 | Sale | EVP & Chief Administrative Off | 15,098 0.0071% | $444.76 | $6.71M | +2.11% | ||
| 2023-03-09 | Sale | EVP & President, Commercial | 2,314 0.0011% | $462.22 | $1.07M | +1.05% | ||
| 2022-06-09 | Sale | EVP & President, Commercial | 522 0.0003% | $490.83 | $256,213 | -1.20% | ||
| 2022-06-06 | Sale | 420 0.0002% | $497.14 | $208,799 | -3.15% | |||
| 2022-05-19 | Sale | director | 990 0.0005% | $468.88 | $464,191 | +0.68% | ||
| 2022-05-18 | Sale | 990 0.0005% | $468.88 | $464,191 | +1.43% |
Insider Historical Profitability
17.1%
| BOUDREAUX GAIL | President and CEO | 126709 0.0546% | $382.48 | 1 | 1 | +5.1% |
| Norwood Felicia F | EVP & President,Gov Health Ben | 27304 0.0118% | $382.48 | 0 | 2 | |
| Haytaian Peter D | EVP & Pres Carelon & CarelonRx | 18887 0.0081% | $382.48 | 0 | 22 | |
| Dixon Robert L JR | director | 9721 0.0042% | $382.48 | 0 | 7 | |
| PERU RAMIRO G | director | 8744 0.0038% | $382.48 | 0 | 15 | |
| Kendrick Charles Morgan JR | EVP & President, Commercial | 8423 0.0036% | $382.48 | 0 | 4 | |
| Penczek Ronald W | CAO & Controller | 1764 0.0008% | $382.48 | 0 | 23 | |
| Beer Lori A | EVP, Specialty Businesses & IT | 113955 0.0491% | $382.48 | 0 | 2 | |
| NUSSBAUM SAMUEL R MD | EVP & Chief Medical Officer | 110973 0.0478% | $382.48 | 0 | 14 | |
| Cannon John | EVP, GC & Chief PAO | 99331 0.0428% | $382.48 | 0 | 6 | |
| BAKER LENOX D JR MD | director | 71155 0.0307% | $382.48 | 0 | 2 | |
| Goulet Kenneth R | EVP, Commercial & Specialty | 71065 0.0306% | $382.48 | 0 | 5 | |
| DeVeydt Wayne S | EVP & Chief Financial Officer | 69607 0.03% | $382.48 | 0 | 13 | |
| Swedish Joseph | Executive Chairman | 61419 0.0265% | $382.48 | 0 | 18 | |
| Sassi Brian A | President & CEO Cons, EVP | 60825 0.0262% | $382.48 | 2 | 2 | +15.56% |
| Gallina John E | EVP & Chief Financial Officer | 54320 0.0234% | $382.48 | 0 | 6 | |
| MCCARTHY GLORIA M | EVP & Chief Administrative Off | 51435 0.0222% | $382.48 | 0 | 20 | |
| SCHAEFER GEORGE A JR | director | 33055 0.0143% | $382.48 | 0 | 2 | |
| HILL JULIE A | director | 31213 0.0135% | $382.48 | 0 | 10 | |
| JOBE WARREN Y | director | 30525 0.0132% | $382.48 | 0 | 3 | |
| Brown Randal L | EVP & Chief HR Officer | 30332 0.0131% | $382.48 | 0 | 3 | |
| RYAN WILLIAM J | director | 27149 0.0117% | $382.48 | 0 | 5 | |
| Levine Harlan A | EVP, CHS | 25244 0.0109% | $382.48 | 0 | 1 | |
| ZORETIC RICHARD C | EVP, Gov Business Division | 24432 0.0105% | $382.48 | 0 | 2 | |
| Tomas Jose D. | EVP & Chief HR Officer | 23913 0.0103% | $382.48 | 0 | 1 | |
| WARD JACKIE M | director | 20860 0.009% | $382.48 | 0 | 1 | |
| BUSH WILLIAM H T | director | 18302 0.0079% | $382.48 | 0 | 1 | |
| ZIELINSKI THOMAS C | EVP & General Counsel | 17910 0.0077% | $382.48 | 0 | 10 | |
| Samitt Craig E | EVP & President, DBG | 17274 0.0074% | $382.48 | 0 | 1 | |
| BURKE SHEILA P | director | 16200 0.007% | $382.48 | 0 | 2 | |
| GRIFFIN BRIAN T | EVP & CEO, IngenioRx | 15863 0.0068% | $382.48 | 0 | 1 | |
| Todt Blair Williams | EVP, CLO & CAO | 12512 0.0054% | $382.48 | 0 | 1 | |
| Schneider Ryan M. | director | 4714 0.002% | $382.48 | 2 | 0 | +24.64% |
| BAYH SUSAN B | director | 0 0% | $382.48 | 0 | 2 | |
| LOGEN ASSET MANAGEMENT LP | 10 percent owner | 0 0% | $382.48 | 0 | 1 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny StocksPrismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.